• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Mutations from bat ACE2 orthologs markedly enhance ACE2-Fc neutralization of SARS-CoV-2

Emily

Editor, Senior Moderator
https://www.biorxiv.org/content/10.1101/2020.06.29.178459v1.abstract
Mutations from bat ACE2 orthologs markedly enhance ACE2-Fc neutralization of SARS-CoV-2

Huihui Mou, Brian D. Quinlan, Haiyong Peng, Yan Guo, Shoujiao Peng, Lizhou Zhang, Meredith E. Davis-Gardner, Matthew R. Gardner, Gogce Crynen, Zhi Xiang Voo, Charles C. Bailey, Michael D. Alpert, Christoph Rader, Hyeryun Choe, Michael Farzan

bioRxiv 2020.06.29.178459; doi: https://doi.org/10.1101/2020.06.29.178459 This article is a preprint and has not been certified by peer review
...
DISCUSSION


Here we show that three ACE2 orthologs – human, pangolin, and R. macrotis bat – associate with the SARS2-RBD more efficiently than with the SARS1-RBD. In contrast, pig, dog, palm civet, and mouse orthologs bound more efficiently to SARS1-RBD, and neither RBD bound R. pusillus bat or rat ACE2. Unexpectedly the RBD of the SARS-like coronavirus RaTG13 isolated from horseshoe bats (R. affinis) did not bind either horseshoe bat ACE2 ortholog tested, indicating that the not-yet-described R. affinis ACE2 varies in significant ways from these horseshoe-bat orthologs. However, unlike the SARS2-RBD, the RaTG13-RBD bound both rat and mouse ACE2 orthologs efficiently...
 
Full summary.

SUMMARY

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike (S) protein mediates infection of cells expressing angiotensin-converting enzyme 2 (ACE2). ACE2 is also the viral receptor of SARS-CoV (SARS-CoV-1), a related coronavirus that emerged in 2002-2003. Horseshoe bats (genus Rhinolophus) are presumed to be the original reservoir of both viruses, and a SARS-like coronavirus, RaTG13, closely related SARS-CoV-2, has been isolated from one horseshoe-bat species. Here we characterize the ability of S-protein receptor-binding domains (RBDs) of SARS-CoV-1, SARS-CoV-2, and RaTG13 to bind a range of ACE2 orthologs. We observed that the SARS-CoV-2 RBD bound human, pangolin, and horseshoe bat (R. macrotis) ACE2 more efficiently than the SARS-CoV-1 or RaTG13 RBD. Only the RaTG13 RBD bound rodent ACE2 orthologs efficiently. Five mutations drawn from ACE2 orthologs of nine Rhinolophus species enhanced human ACE2 binding to the SARS-CoV-2 RBD and neutralization of SARS-CoV-2 by an immunoadhesin form of human ACE2 (ACE2-Fc). Two of these mutations impaired neutralization of SARS-CoV-1. An ACE2-Fc variant bearing all five mutations neutralized SARS-CoV-2 five-fold more efficiently than human ACE2-Fc. These data narrow the potential SARS-CoV-2 reservoir, suggest that SARS-CoV-1 and -2 originate from distinct bat species, and identify a more potently neutralizing form of ACE2-Fc.
 
Back
Top Bottom